-
Je něco špatně v tomto záznamu ?
Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes
A. Špolcová, M. Holubová, B. Mikulášková, V. Nagelová, A. Štofková, Z. Lacinová, J. Jurčovičová, M. Haluzík, L. Maletínská, B. Železná
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- experimentální diabetes mellitus metabolismus MeSH
- fibroblastové růstové faktory biosyntéza krev metabolismus MeSH
- hnědá tuková tkáň metabolismus MeSH
- hypothalamus metabolismus MeSH
- inzulinová rezistence * MeSH
- játra metabolismus MeSH
- lipodystrofie metabolismus MeSH
- messenger RNA biosyntéza MeSH
- myši MeSH
- neuropeptidy metabolismus MeSH
- pankreas metabolismus MeSH
- receptor fibroblastových růstových faktorů, typ 1 metabolismus MeSH
- slezina metabolismus MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Patients with obesity and type 2 diabetes often display high levels of the anti-diabetic factor fibroblast growth factor-21 (FGF21), suggesting that the overproduction of FGF21 may result from increased adiposity in an attempt by white adipose tissue (WAT) to counteract insulin resistance. However, the production of FGF21 diabetes in the absence of WAT has not been examined. In this study, we investigated the effects of lipodystrophy in A-ZIP F-1 mice on FGF21 production in relation to diabetes. A-ZIP F-1 mice displayed high FGF21 plasma levels resulting from enhanced FGF21 mRNA expression in the liver. Concomitant enhancement of FGF21 receptor (FGFR1) and glucose transporter 1 (GLUT-1) mRNA expression was observed in the muscles of A-ZIP F-1 mice. Furthermore, the activation of hypothalamic NPY and AgRP mRNA expression positively correlated with plasma levels of FGF21 but not active ghrelin. Our study demonstrates that an increased FGF21 plasma level in lipodystrophic A-ZIP F-1 mice results mainly from up-regulated liver production but does not suffice to overcome the lipodystrophy-induced severe type 2-diabetes and insulin resistance in the liver linked to the augmented liver fat deposition.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15026727
- 003
- CZ-PrNML
- 005
- 20150818150005.0
- 007
- ta
- 008
- 150811s2014 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932714 $2 doi
- 035 __
- $a (PubMed)24908095
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Špolcová, Andrea $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic, $7 xx0248498
- 245 10
- $a Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes / $c A. Špolcová, M. Holubová, B. Mikulášková, V. Nagelová, A. Štofková, Z. Lacinová, J. Jurčovičová, M. Haluzík, L. Maletínská, B. Železná
- 520 9_
- $a Patients with obesity and type 2 diabetes often display high levels of the anti-diabetic factor fibroblast growth factor-21 (FGF21), suggesting that the overproduction of FGF21 may result from increased adiposity in an attempt by white adipose tissue (WAT) to counteract insulin resistance. However, the production of FGF21 diabetes in the absence of WAT has not been examined. In this study, we investigated the effects of lipodystrophy in A-ZIP F-1 mice on FGF21 production in relation to diabetes. A-ZIP F-1 mice displayed high FGF21 plasma levels resulting from enhanced FGF21 mRNA expression in the liver. Concomitant enhancement of FGF21 receptor (FGFR1) and glucose transporter 1 (GLUT-1) mRNA expression was observed in the muscles of A-ZIP F-1 mice. Furthermore, the activation of hypothalamic NPY and AgRP mRNA expression positively correlated with plasma levels of FGF21 but not active ghrelin. Our study demonstrates that an increased FGF21 plasma level in lipodystrophic A-ZIP F-1 mice results mainly from up-regulated liver production but does not suffice to overcome the lipodystrophy-induced severe type 2-diabetes and insulin resistance in the liver linked to the augmented liver fat deposition.
- 650 _2
- $a hnědá tuková tkáň $x metabolismus $7 D002001
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a experimentální diabetes mellitus $x metabolismus $7 D003921
- 650 _2
- $a fibroblastové růstové faktory $x biosyntéza $x krev $x metabolismus $7 D005346
- 650 _2
- $a hypothalamus $x metabolismus $7 D007031
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a lipodystrofie $x metabolismus $7 D008060
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a neuropeptidy $x metabolismus $7 D009479
- 650 _2
- $a pankreas $x metabolismus $7 D010179
- 650 _2
- $a messenger RNA $x biosyntéza $7 D012333
- 650 _2
- $a receptor fibroblastových růstových faktorů, typ 1 $x metabolismus $7 D051496
- 650 _2
- $a slezina $x metabolismus $7 D013154
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Holubová, Martina $7 xx0278717 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic,
- 700 1_
- $a Lapčíková, Barbora, $d 1968- $7 mzk2007386080 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic,
- 700 1_
- $a Nagelová, Veronika $7 _AN073539 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic,
- 700 1_
- $a Štofková, Andrea $7 xx0246901 $u Department of Normal, Pathological and Clinical Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Lacinová, Zuzana $7 _AN065421 $u Third Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Jurčovičová, Jana $7 xx0103077 $u Department of Normal, Pathological and Clinical Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Haluzík, Michal $7 xx0063775 $u Third Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Maletínská, Lenka, $d 1965- $7 xx0080235 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic,
- 700 1_
- $a Železná, Blanka $7 xx0206931 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic,
- 773 0_
- $w MED00003824 $t Physiological research Academia Scientiarum Bohemoslovaca $x 1802-9973 $g Roč. 63, č. 4 (2014), s. 483-490
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20150811 $b ABA008
- 991 __
- $a 20150818140054 $b ABA008
- 999 __
- $a ok $b bmc $g 1087935 $s 909763
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c 4 $d 483-490 $e 20140605 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20150811